Skip to main content

Rivaroxaban trends toward higher thrombotic risk than vitamin K antagonists in APS

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Rivaroxaban trends toward higher thrombotic risk than vitamin K antagonists in APS

User login

Username

Password

Reset your password

Type	Lead	score